New CEO heads Symphony's quartet

Share this article:

Frank Lavelle officially became CEO of data and analytics provider Symphony Health Solutions in mid-January.

He is orchestrating the four companies of which Symphony is composed: Source Healthcare Analytics, ImpactRx, TargetRx and AlphaDetail.

Symphony was formed by parent Symphony Technology Group last May after the private equity firm acquired the Source business from Wolters Kluwer for an undisclosed sum.

After the sale, Source's co-presidents Bob Jansen and Michelle Woker stayed on. A month later, Symphony Health announced that it had appointed an IMS Health and Thomson Healthcare veteran as its new CEO, but apparently the appointment didn't work out.

For the past four years, Lavelle led the educational division of SunGard Data Systems. Before that, he served as CEO for Siemens Medical Solutions and president for Medquist.
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?